Lamivudine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lamivudine" in English language version.

refsWebsite

Global rank English rank

8nih.gov

4^th place

6web.archive.org

1^st place

4doi.org

2^nd place

2europa.eu

68^th place

117^th place

2books.google.com

3^rd place

2semanticscholar.org

11^th place

8^th place

1drugs.com

399^th place

333^rd place

1fda.gov

447^th place

338^th place

1catie.ca

low place

1handle.net

102^nd place

76^th place

1stanford.edu

179^th place

183^rd place

1yale.edu

565^th place

460^th place

1uspto.gov

1,459^th place

991^st place

1aau.edu

low place

1thebody.com

low place

aau.edu

Soderstrom J (2003). "National Institutes of Health: Moving Research from the Bench to the Bedside". Archived from the original on 4 March 2016.

books.google.com

Therapy of Viral Infections Volume 15 of Topics in Medicinal Chemistry. Springer. 2015. p. 6. ISBN 9783662467596. Archived from the original on 15 August 2016.
Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 506. ISBN 9783527607495.

catie.ca

"3TC (lamivudine, Epivir)". Catie. 2014. Retrieved 22 August 2022.

doi.org

Cane PA, Mutimer D, Ratcliffe D, Cook P, Beards G, Elias E, Pillay D (1999). "Analysis of hepatitis B virus quasispecies changes during emergence and reversion of lamivudine resistance in liver transplantation". Antiviral Therapy. 4 (1): 7–14. doi:10.1177/135965359900400101. PMID 10682123. S2CID 35040816.
Kasırga E (April 2015). "Lamivudine resistance in children with chronic hepatitis B". World Journal of Hepatology. 7 (6): 896–902. doi:10.4254/wjh.v7.i6.896. PMC 4411531. PMID 25937866.
Fox Z, Dragsted UB, Gerstoft J, Phillips AN, Kjaer J, Mathiesen L, et al. (2006). "A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial". Antiviral Therapy. 11 (6): 761–770. doi:10.1177/135965350601100608. PMID 17310820. S2CID 25783477.
Koziel MJ, Peters MG (April 2007). "Viral hepatitis in HIV infection". The New England Journal of Medicine. 356 (14): 1445–1454. doi:10.1056/NEJMra065142. PMC 4144044. PMID 17409326.

drugs.com

"Lamivudine". The American Society of Health-System Pharmacists. Archived from the original on 2 June 2016. Retrieved 31 July 2016.

europa.eu

ema.europa.eu

"Epivir EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 29 November 2020.
"Zeffix EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 28 November 2020.

fda.gov

nctr-crs.fda.gov

"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

nih.gov

pubmed.ncbi.nlm.nih.gov

Cane PA, Mutimer D, Ratcliffe D, Cook P, Beards G, Elias E, Pillay D (1999). "Analysis of hepatitis B virus quasispecies changes during emergence and reversion of lamivudine resistance in liver transplantation". Antiviral Therapy. 4 (1): 7–14. doi:10.1177/135965359900400101. PMID 10682123. S2CID 35040816.
Kasırga E (April 2015). "Lamivudine resistance in children with chronic hepatitis B". World Journal of Hepatology. 7 (6): 896–902. doi:10.4254/wjh.v7.i6.896. PMC 4411531. PMID 25937866.
Fox Z, Dragsted UB, Gerstoft J, Phillips AN, Kjaer J, Mathiesen L, et al. (2006). "A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial". Antiviral Therapy. 11 (6): 761–770. doi:10.1177/135965350601100608. PMID 17310820. S2CID 25783477.
Koziel MJ, Peters MG (April 2007). "Viral hepatitis in HIV infection". The New England Journal of Medicine. 356 (14): 1445–1454. doi:10.1056/NEJMra065142. PMC 4144044. PMID 17409326.

dailymed.nlm.nih.gov

"Epivir- lamivudine tablet, film coated Epivir- lamivudine solution". DailyMed. 1 August 2020. Retrieved 28 November 2020.
"Epivir HBV- lamivudine tablet, film coated Epivir HBV- lamivudine solution". DailyMed. 17 August 2020. Retrieved 28 November 2020.

ncbi.nlm.nih.gov

Kasırga E (April 2015). "Lamivudine resistance in children with chronic hepatitis B". World Journal of Hepatology. 7 (6): 896–902. doi:10.4254/wjh.v7.i6.896. PMC 4411531. PMID 25937866.
Koziel MJ, Peters MG (April 2007). "Viral hepatitis in HIV infection". The New England Journal of Medicine. 356 (14): 1445–1454. doi:10.1056/NEJMra065142. PMC 4144044. PMID 17409326.

semanticscholar.org

api.semanticscholar.org

Cane PA, Mutimer D, Ratcliffe D, Cook P, Beards G, Elias E, Pillay D (1999). "Analysis of hepatitis B virus quasispecies changes during emergence and reversion of lamivudine resistance in liver transplantation". Antiviral Therapy. 4 (1): 7–14. doi:10.1177/135965359900400101. PMID 10682123. S2CID 35040816.
Fox Z, Dragsted UB, Gerstoft J, Phillips AN, Kjaer J, Mathiesen L, et al. (2006). "A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial". Antiviral Therapy. 11 (6): 761–770. doi:10.1177/135965350601100608. PMID 17310820. S2CID 25783477.

stanford.edu

hivdb.stanford.edu

"Index". Archived from the original on 1 July 2010. Retrieved 23 July 2010. Stanford University Drug Resistance Database.

thebody.com

Gilden D (2000). "The Wide-Ranging Effects of Nucleoside Analogs:A Look at Mitochondrial Toxicity". Archived from the original on 16 September 2016.

uspto.gov

"US Patent Office" (PDF). Archived (PDF) from the original on 16 June 2016.

web.archive.org

"Lamivudine". The American Society of Health-System Pharmacists. Archived from the original on 2 June 2016. Retrieved 31 July 2016.
Therapy of Viral Infections Volume 15 of Topics in Medicinal Chemistry. Springer. 2015. p. 6. ISBN 9783662467596. Archived from the original on 15 August 2016.
"Index". Archived from the original on 1 July 2010. Retrieved 23 July 2010. Stanford University Drug Resistance Database.
"US Patent Office" (PDF). Archived (PDF) from the original on 16 June 2016.
Soderstrom J (2003). "National Institutes of Health: Moving Research from the Bench to the Bedside". Archived from the original on 4 March 2016.
Gilden D (2000). "The Wide-Ranging Effects of Nucleoside Analogs:A Look at Mitochondrial Toxicity". Archived from the original on 16 September 2016.

yale.edu

medicine.yale.edu

"Hunting Down HIV".